Steroid refractory dermatomyositis following combination dabrafenib and trametinib therapy.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Rheumatology

• Publication date

  2018-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/rheumatology/key080PMID 29617934
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial

  2017cited by this paper
• Immunomodulating property of MAPK inhibitors: from translational knowledge to clinical implementation

  2017cited by this paper
• MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade.

  2016cited by this paper
• Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors

  2015cited by this paper
• MEK inhibition prevents tumour‐shed transforming growth factor‐β‐induced T‐regulatory cell augmentation in tumour milieu

  2015cited by this paper
• T Cell-Signaling Network Analysis Reveals Distinct Differences between CD28 and CD2 Costimulation Responses in Various Subsets and in the MAPK Pathway between Resting and Activated Regulatory T Cells

  2011cited by this paper
• Role of regulatory T cells in a new mouse model of experimental autoimmune myositis.

  2009cited by this paper
• Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy

  2005cited by this paper

• Large-vessel vasculitis possibly induced by BRAF and MEK inhibitors for BRAF V600E positive lung adenocarcinoma

  2024cites this paper
• Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma

  2022influential citation
• Superior oblique myositis following targeted therapy of metastatic papillary carcinoma of the thyroid gland.

  2021cites this paper
• Junctional scotoma in moyamoya disease.

  2021cites this paper
• Granulomatosis with polyangiitis in a patient treated with dabrafenib and trametinib for BRAF V600E positive lung adenocarcinoma

  2020cites this paper
• Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib.

  2020cites this paper
• Necrotizing myositis in a rectus muscle arising in the setting of long-standing Langerhans cell histiocystosis and recent dabrafenib treatment

  2020cites this paper
• Dabrafenib/trametinib

  2018cites this paper